Cite
HARVARD Citation
Younossi, Z. et al. (2016). Sofosbuvir and ledipasvir improve patient‐reported outcomes in patients co‐infected with hepatitis C and human immunodeficiency virus. Journal of viral hepatitis. 23 (11), pp. 857-865. [Online].